Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Senior Vice President, R&D
-
Stock Symbol
-
TVTX on Nasdaq
William E. Rote - trading volume in the past year for Travere Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
98.5K |
$2.32M |
$23.53 |
Feb 12, 2025 |
Direct |
|
|
| Performance-based restricted stock units |
0 |
$0 |
$23.53 |
Feb 10, 2025 |
Direct |
Common Stock |
|
| Employee stock option (right to buy) |
58K |
|
|
Jan 31, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.